FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078249 [Registered on: 17/12/2024] Trial Registered Prospectively
Last Modified On: 17/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Effect of Tilmooladi Churna with Lekhaniya Matra Basti on Polycystic Ovarian Syndrome. 
Scientific Title of Study   A CLINICAL STUDY TO EVALUATE THE EFFICACY OF TILMOOLADI CHURNA AND LEKHANIYA MATRA BASTI ON VATA-KAPHAJA ARTAVADUSHTI W.S.R.TO POLYCYSTIC OVARIAN SYNDROME. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anita Mayal 
Designation  M.S. Scholar 
Affiliation  Madan Mohan Malviya Govt. Ayurved College Udaipur Rajasthan 
Address  PG Dept. of Prasuti Tantra & Stree Roga Madan Mohan Malviya Govt. Ayurved College Radaji Circle Ambamata Udaipur Rajasthan

Udaipur
RAJASTHAN
313001
India 
Phone  8905046050  
Fax    
Email  anitamayal.11@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Narendra Kumar Meena 
Designation  Associate Professor & HOD and Guide 
Affiliation  Madan Mohan Malviya Govt. Ayurved College Udaipur Rajasthan 
Address  PG Dept. of Prasuti Tantra & Stree Roga Madan Mohan Malviya Govt. Ayurved College Radaji Circle Ambamata Udaipur Rajasthan

Udaipur
RAJASTHAN
313001
India 
Phone  09950129673  
Fax    
Email  NARENDERMEENA42@YAHOO.COM  
 
Details of Contact Person
Public Query
 
Name  Dr Narendra Kumar Meena 
Designation  Associate Professor & HOD and Guide 
Affiliation  Madan Mohan Malviya Govt. Ayurved College Udaipur Rajasthan 
Address  PG Dept. of Prasuti Tantra & Stree Roga Madan Mohan Malviya Govt. Ayurved College Radaji Circle Ambamata Udaipur Rajasthan

Udaipur
RAJASTHAN
313001
India 
Phone  09950129673  
Fax    
Email  NARENDERMEENA42@YAHOO.COM  
 
Source of Monetary or Material Support  
Madan Mohan Malviya Govt Ayurved College Udaipur 313001 Rajasthan India 
 
Primary Sponsor  
Name  Madan Mohan Malviya Govt Ayurved College Udaipur Rajasthan 
Address  Madan Mohan Malviya Govt Ayurved College Udaipur 313001 Rajasthan India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anita Mayal  Madan Mohan Malviya Govt Ayurved College Udaipur  O.P.D. No.-5 Prasuti Tantra & Stree Roga Department Udaipur Rajasthan
Udaipur
RAJASTHAN 
8905046050

anitamayal.11@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE, Madan Mohan Malviya Govt Ayurved College Udaipur RAJASTHAN  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N914||Secondary oligomenorrhea. Ayurveda Condition: ARTAVADOSHAH/ARTAVADUSHTIH/RAJODOSHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Tilmooladi Churna, Reference: Yogratnakar, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -lukewarm water), Additional Information: -
2Intervention ArmProcedure-mAtrAbastiH, मात्राबस्तिः (Procedure Reference: Sharangdhar Samhita, Procedure details: 30ml per rectum for 7 days after completion of menses for 3 consecutive menstrual cycle.)
(1) Medicine Name: Lekhaniya Matra Basti, Reference: Sharangdhar Samhita, Route: Rectal, Dosage Form: Taila, Dose: 30(ml), Frequency: od, Duration: 90 Days
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1. Patient willing for the trial
2. P[atient aged between 16 years to 40 years with, fulfilling at least 2 of following 3 criteria:
(American Society for Reproductive Medicine)
i. Patients having polycystic ovary diagnosed by USG.
ii. Patients having Oligomenorrhoea, and or anovulation.
iii.Clinical evidence of Hyperandrogenism. 
 
ExclusionCriteria 
Details  1.⁠ ⁠Patient not willing for trial.
2.⁠ ⁠Patient below age of 16 years and above age of 40 years.
3.⁠ ⁠Patient of amenorrhea with congenital anomalies.
4.⁠ ⁠Cervical tumour, polyp, CA cervix, NC-CAH
5.⁠ ⁠Uterine fibroids, Cushing Syndrome, Thyroid disorders, Hyperprolactinemia.
6.⁠ ⁠Pregnant women.
7.⁠ ⁠Patients having BMI less than 18.5. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement in signs and symptoms after treatment  12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in other associated symptoms   12 weeks 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response - None of the above

  3. Who will be able to view these files?
    Response (Others) -  nobody

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response (Others) -  NIL

  6. For how long will this data be available start date provided 20-12-2024 and end date provided 20-12-2029?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   This trial study is about to evaluate the efficacy of Tilmooladi Churna and Lekhaniya Matra Basti on Vata-Kaphaja Artavadushti w.s.r. to Polycystic Ovarian Syndrome.
There will be a single group of 30 patients.
Patients will be treated with Tilmooladi Churna 3 gm BD with lukewarm water and Lekhaniya Matra Basti 30 ml (per rectum) for 7 days for 3 consecutive menstrual cycle.
This trial study will be carried out for 3 months.
 
Close